BSE List Price : ₹720.00

NSE List Price : ₹720.00

Subscription

Category	Times
QIBs	3.09x
HNIs	0.66x
Retail	2.00x
Total : 2.23x

IPO Market Lot(s) Distribution

Application	Lot Size	Shares	Amount
Retail Minimum	1	21	₹14,553
Retail Maximum	13	273	₹189,189
S - HNI Minimum	14	294	₹203,742
S - HNI Maximum	68	1,428	₹989,604
B - HNI Minimum	69	1,449	₹1,004,157

About the Company

Paras Healthcare Limited operates a network of eight multi-specialty hospitals under the Paras Health brand. As of 30 June 2026 the company had a total capacity of 2,211 beds across five states and one Union Territory.

Business Model: The company earns revenue by providing tertiary and quaternary healthcare services through hospital admissions outpatient consultations surgeries diagnostic services and specialised medical treatments.

Products & Services

• Cardiac sciences

• Oncology sciences

• Neurosciences

• Gastro sciences

• Orthopaedics and sports injury

• Renal sciences

• In-patient and outpatient services

Company Financial Report

_{Amount ₹ in Crores}

Period Ended	Revenue	Expense	PAT	Assets
2024	₹1151.02	₹1144.39	₹-15.33	₹14776.58
2025	₹1314.21	₹1364.24	₹-57.99	₹18104.51
2026	₹1628.79	₹1552.75	₹43.83	₹20711.41
Jun 2026	₹478.75	₹430.63	₹49.68	₹22028.78

Company Promoter

Dr. Dharminder Kumar Nagar

Know before investing

• • Strengths

  • Established hospital network: Eight hospitals across North and East India.

  • Specialised treatments: Focus on complex and specialised medical care.

  • Revenue growth: Revenue from operations increased from 1129 crore in FY2024 to 1606 crore in FY2026.

  • Improved occupancy: Bed occupancy increased to 61.75% in FY2026 from 50.78% in FY2025.

• • Risks

  • High borrowings: The company and its subsidiaries had aggregate secured borrowings of 990.33 crore as of 31 August 2026.

  • Geographical concentration: A significant portion of revenue comes from hospitals in North India.

  • Dependence on specialised treatments: Major clinical specialties contribute a substantial share of revenue.

  • Staff attrition: High employee attrition may affect recruitment operational costs and service delivery.

  • Hospital occupancy: Lower-than-expected patient numbers at newer hospitals may affect profitability.

Objects of the Issue & Utilisation of proceeds

Purpose	Amount
Repayment or prepayment of certain borrowings of Paras Healthcare Limited	320.90 crore
Investment in subsidiary Plus Medicare Hospitals Private Limited for repayment or prepayment of borrowings	54.10 crore
General corporate purposes	Remaining eligible net proceeds

Company Address

Paras Healthcare Limited
1 st Floor, Tower B, Paras Twin Towers,
Golf Course Road, Sector 54,
Gurugram – 122002, Haryana, India
Phone: +91 124 430 2163
Email: cs@parashospitals.com
Website: https://www.parashospitals.com/

IPO Registrar

MUFG Intime India Private Ltd
Phone: +91-22-4918 6270
Email: parashealthcare.ipo@linkintime.co.in
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html